Cell Design Labs: Kite and CDL to develop way of dialing down CAR-T activity for safer cell therapies
Kite Pharma and Cell Design Labs (CDL) have teamed up to develop "on/off" dials for CAR-T cell therapies that will reduce off site effects.
Read full article »
Co-Founder & CEO
Brian Atwood
Cell Design Labs focuses on developing CAR-T and T cell receptor therapies for the treatment of cancer.
Read more